Pinned Tweet
Last week, I defended my PhD within @UMassDerm and @UMassChanPII ! Thank you to my incredible mentors, Ann Rothstein, Mehdi Rashighi, and Michael @BrehmLab.
Any return-to-clinic tips are greatly appreciated 🩺❤️
Jane Chuprin-Bucher retweeted
We lost two pregnancies a few years ago before our healthy, perfect baby girl was born. We never found out why, or what we could do to change the outcome. As NASA and SpaceX engineers, when a satellite fails, it's not acceptable and we investigate why. I was shocked at the lack of answers in miscarriages. We discovered the research simply hasn't been done, and the funding levels have been abysmal.
This is why we started the Delphine Foundation. Our ambitious goal is to dramatically reduce miscarriage rates, and we're learning so much about preconception, fertility, and miscarriage science to improve outcomes. This is one of the most meaningful things I've worked on. If it resonates with you, or with someone you know, I'd be grateful if you shared with your network. 👶 🤱 👼 🛰️ 🚀 😍
delphinefoundation.org/
Jane Chuprin-Bucher retweeted
This is a preview of the future. In the years ahead, people with a high-risk of cancer will be eligible to receive a vaccine that revs up their specific immune response for prevention
Prevention >> Treatment.
A vaccine to prevent colon cancer.
Proof-of-concept for strong immune response and safety via neoantigens given to people with mutations for Lynch syndrome
nature.com/articles/s41591-0…
Jane Chuprin-Bucher retweeted
The human proteomic revolution proceeds with high-throughput assessment, AI analytics, correlation with health and disease, drug interactions, biomarkers
cell.com/cell/fulltext/S0092…
Jane Chuprin-Bucher retweeted
We’ve just finished writing the missing 15,616 Wikipedia articles to get complete coverage of all 19,255 human genes. We used PaperQA2, which has higher accuracy than existing human-written Wikipedia articles, as judged by blinded biology PhD students and postdocs. 1/5
Jane Chuprin-Bucher retweeted
A biomedical first: spatial biology used to find a lifesaving treatment!
Just published @Nature
Deep visual proteomics with #AI leads to effective JAKI treatment for 7 patients with toxic epidermal necrolysis
nature.com/articles/s41586-0… @labs_mann @NordmannThierry
Jane Chuprin-Bucher retweeted
#JustIn: @UMassChan researcher Victor R. Ambros, PhD, the Silverman Chair in Natural Sciences and professor of molecular medicine, has received the 2024 @NobelPrize in Physiology or Medicine for the discovery of microRNA. #NobelPrize #medicine #BreakingNews #Worcester @ProgMolMed
Fantastic review @Mingqi7up, awesome to see it finally out!
nature.com/articles/s41590-0…
I hope this is a helpful review!
Appreciate the opportunity to co-write this review in @NatImmunol with my mentor @FitzgeraldKate. Thanks to all the reviewers' comments which significantly elevated our work and thanks to the unsung artists for their art!
1
5
677
Jane Chuprin-Bucher retweeted
🚨 Calling all new postdocs 🚨
@UMassChan just launched a new Early Independence Fellows program!
Come start your lab at UMass Chan, truly an amazing place to work with world-class colleagues!
✅ Must be within 2 yrs of terminal degree
✅ $440k/yr of support for 5 years! 😱
UMass Chan Medical School seeks the next generation of scientific leaders! Join our research community as a UMass Chan Early Independence Fellow. Get 3-5 years of support. Apply by Dec 1: academicjobsonline.org/ajo/j… @UMassChan @RTI_UMassChan
Jane Chuprin-Bucher retweeted
Excited to share our latest pancreatic cancer findings in collaboration with @AtukoralePU's group and led by former postdoc Loretah Chibaya and current research associate Kelly DeMarco in our lab.
science.org/doi/10.1126/scit…
Jane Chuprin-Bucher retweeted
You can read our new study, out now in @JCI_Insight! (tinyurl.com/4bjcraeu) We examine how expression of a STING gain-of-function (GOF) mutation in radioresistant host cells results in the development of lymphocyte autoimmunity. Some highlights from our study: (1/7)
Jane Chuprin-Bucher retweeted
Once a month, Talaya Reid flies from Philly to Boston to travel to @UMassChan in #Worcester to participate in a clinical research study exploring the use of CAR T cell treatment in lupus nephritis.
See her story here:
umassmed.edu/news/news-archi… @UMassLupus @UMassCancerCtr
Kind of crazy that T and B cells were only discovered in 1968 and innate immunity got its moment in 1989 considering the revolution of targeted biologics today. What's going to happen in the next 30-50 years?
1
15
1,116
Jane Chuprin-Bucher retweeted
I’m starting a company.
An internet-scale dataset is created every day that can be used to cure diseases.
ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ
Yet decisions for developing new drugs use a tiny fraction of it.
ㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤㅤ
After years of building and investing in therapeutics companies, I'm convinced that this is about to change.
·
There are two kinds of knowledge. Facts, and connections. We have an abundance of known facts about biology, but we have barely begun to make all the connections.
ㅤ
Our company is connecting the world's pharmaceutical data, drawing a coherent understanding from an archipelago of information.
Thousands of decisions behind breakthrough drugs—from experimental design to new product planning—can be augmented by this scientific intelligence.
·
We are partnering with drug developers who’ve dedicated their careers to their craft.
We know that engineering tools for those at the pinnacle of human expertise is not going to be easy.
But it will change how life-saving discoveries are brought to patients.
If this sounds like fun, reach out. We're recruiting founding engineers.
Jane Chuprin-Bucher retweeted
Frequency is back for Summer 2024. Apply by July 2!
If you are interested in starting biotech companies, this is a 1 week, part time, crash course experience in all aspects of early stage company building.
Alumni have started leading companies + joined top VC firms worldwide.
Jane Chuprin-Bucher retweeted
Job alert! We are recruiting a research associate to join our lab! The position involves a combination of lab and mouse colony management and designing and performing experiments with a talented and collaborative team of cancer researchers. Please RT!
ummsjobs.com/job/10416/
Jane Chuprin-Bucher retweeted
Hiring a part-time researcher in bio and health 🧬
Specifically interested in folks with deep experience in therapeutic platforms.
Details below and DM's open 🚀
Send applications to [email protected]
Jane Chuprin-Bucher retweeted
We are incredibly excited to launch the new Finberg Physician-Scientist Training Program in the Internal Medicine Residency Program @UMassChan , named in honor of our late Chair, an archetypal physician-scientist. World class training in medicine and science. Please RT.
The Finberg Physician-Scientist Training Program @UMassChan is now accepting applications! Learn more about how our training in clinical medicine & biomedical research supports internal medicine residents at all stages of their professional journey. umassmed.edu/finbergpstp/

ALT Blue petri dishes with this text overlayed: The Robert W. Finberg Physician Scientist Training Program at UMass Chan Medical School is now accepting applications. The program offers comprehensive training through mentorship, fellowship planning and curriculum specifically designed to prepare trainees for careers as physician-scientists. Learn more and apply at www.umassmed.edu/finbergpstp





























